Olfr967, a member of the olfactory receptor family, plays a crucial role in the sense of smell within mammals. This receptor, primarily expressed in olfactory sensory neurons, is responsible for detecting and recognizing specific odor molecules in the environment. Olfr967 is integral to the perception of various scents, contributing to the complex mechanism by which organisms distinguish and interpret odorants. Functionally, Olfr967 acts as a transmembrane protein that interacts with odor molecules, initiating a cascade of intracellular events that ultimately lead to the perception of a particular smell.
The activation of Olfr967 is governed by intricate mechanisms within olfactory sensory neurons. When odor molecules enter the nasal epithelium and bind to Olfr967, they trigger a signaling pathway that begins with the activation of a G-protein coupled receptor (GPCR). This activation, in turn, stimulates the production of second messengers, such as cyclic adenosine monophosphate (cAMP) or cyclic guanosine monophosphate (cGMP), depending on the specific olfactory receptor. These second messengers play a pivotal role in amplifying the initial signal. Increased cAMP or cGMP levels lead to the activation of protein kinases, such as protein kinase A (PKA) or protein kinase G (PKG), initiating a cascade of phosphorylation events. These events ultimately result in the depolarization of olfactory sensory neurons and the generation of action potentials that travel to the brain, where the odor is perceived and identified. In summary, Olfr967 is a vital component of the olfactory system, contributing to the detection and discrimination of various odorants. Its activation involves a series of intricate signaling events, beginning with the binding of odor molecules and culminating in the transmission of sensory information to the brain. Understanding the mechanisms of Olfr967 activation is essential for unraveling the complexities of olfaction and how organisms perceive and respond to their environment through the sense of smell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate protein kinase C (PKC), which may impact Olfr967 activation via PKC-dependent pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a phosphodiesterase (PDE) inhibitor that can increase cAMP levels, potentially affecting Olfr967 activation through cAMP signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a ligand for nuclear receptors and may influence Olfr967 activation through nuclear receptor-mediated pathways. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Bromo-cGMP is a cyclic guanosine monophosphate (cGMP) analog that could activate Olfr967 through cGMP-mediated pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin is a calcium ionophore that can increase intracellular calcium levels, potentially impacting Olfr967 activation via calcium-dependent signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is another calcium ionophore that may activate Olfr967 by increasing intracellular calcium concentrations. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits endoplasmic reticulum calcium pumps, leading to increased cytosolic calcium levels, which might affect Olfr967 activation via calcium signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic agonist that could activate Olfr967 through β-adrenergic receptor-mediated pathways. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Vitamin A is the alcohol form of vitamin A and may influence Olfr967 activation via retinoic acid production or other vitamin A-related pathways. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Cyclic AMP (cAMP) is a second messenger that can directly activate cAMP-dependent signaling pathways, potentially impacting Olfr967 activation. | ||||||